KVUE · KENVUE INC. · Top AI ETF

Back to holdings

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements.

Close · 3M

+7.23%

Held by 2 AI ETFs

LQAI1.900%

as of Oct 22

PQUS0.060%

as of Oct 23

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals14

Win rate79% (11/14)

Avg buy return+3.25%

LQAInow 1.900% of fund30 signals

LQAI · Accumulation · 5d

weight 1.650% → 1.900% (+0.250 pp)·stock up 12.5% in the 30 days before

Oct 22·entry $19.88·now $19.57Fresh

-1.56%

since Oct 22

LQAI · Accumulation · 5d

weight 1.640% → 1.830% (+0.190 pp)·stock up 9.1% in the 30 days before

Oct 20·entry $19.28·now $19.57Fresh

+1.50%

since Oct 20

LQAI · Accumulation · 5d

weight 1.610% → 1.810% (+0.200 pp)·stock up 5.8% in the 30 days before

Oct 16·entry $18.91·now $19.57Drifting

+3.49%

since Oct 16

LQAI · Weight increase · 2d

weight 1.650% → 1.760% (+0.110 pp)·stock up 4.7% in the 30 days before

Oct 15·entry $18.67·now $19.57Drifting

+4.82%

since Oct 15

LQAI · Weight decrease · 3d

weight 1.680% → 1.600% (-0.080 pp)·stock down 10.1% in the 30 days before

Oct 2·entry $17.20·now $19.57

+13.78%

since Oct 2

LQAI · Weight decrease · 2d

weight 1.680% → 1.610% (-0.070 pp)·stock down 8.2% in the 30 days before

Oct 1·entry $17.22·now $19.57

+13.65%

since Oct 1

LQAI · Weight increase · 3d

weight 1.590% → 1.680% (+0.090 pp)·stock down 6.6% in the 30 days before

Sep 29·entry $17.91·now $19.57Drifting

+9.27%

since Sep 29

LQAI · Weight increase · 2d

weight 1.590% → 1.640% (+0.050 pp)·stock down 6.9% in the 30 days before

Sep 28·entry $17.88·now $19.57Drifting

+9.45%

since Sep 28

LQAI · Weight decrease · 4d

weight 1.680% → 1.580% (-0.100 pp)·stock down 6.7% in the 30 days before

Sep 21·entry $17.67·now $19.57

+10.75%

since Sep 21

LQAI · Weight decrease · 3d

weight 1.680% → 1.630% (-0.050 pp)·stock down 6.9% in the 30 days before

Sep 18·entry $17.81·now $19.57

+9.88%

since Sep 18

LQAI · Weight decrease · 2d

weight 1.680% → 1.650% (-0.030 pp)·stock down 4.9% in the 30 days before

Sep 17·entry $17.87·now $19.57

+9.51%

since Sep 17

LQAI · Weight increase · 2d

weight 1.630% → 1.680% (+0.050 pp)·stock down 6.7% in the 30 days before

Sep 15·entry $17.92·now $19.57Drifting

+9.21%

since Sep 15

LQAI · Weight decrease · 4d

weight 1.770% → 1.620% (-0.150 pp)·stock down 6.7% in the 30 days before

Sep 9·entry $17.75·now $19.57

+10.25%

since Sep 9

LQAI · Weight decrease · 3d

weight 1.770% → 1.670% (-0.100 pp)·stock down 4.4% in the 30 days before

Sep 8·entry $18.39·now $19.57

+6.42%

since Sep 8

LQAI · Weight decrease · 2d

weight 1.770% → 1.700% (-0.070 pp)·stock down 2.3% in the 30 days before

Sep 4·entry $18.74·now $19.57

+4.43%

since Sep 4

LQAI · Weight increase · 2d

weight 1.690% → 1.770% (+0.080 pp)·stock down 2.1% in the 30 days before

Sep 2·entry $19.13·now $19.57Drifting

+2.30%

since Sep 2

LQAI · Weight decrease · 3d

weight 1.750% → 1.710% (-0.040 pp)·stock down 3.0% in the 30 days before

Aug 27·entry $19.20·now $19.57

+1.93%

since Aug 27

LQAI · Weight decrease · 2d

weight 1.750% → 1.720% (-0.030 pp)·stock down 2.7% in the 30 days before

Aug 26·entry $19.22·now $19.57

+1.82%

since Aug 26

LQAI · Weight increase · 2d

weight 1.680% → 1.750% (+0.070 pp)·stock up 0.8% in the 30 days before

Aug 24·entry $19.43·now $19.57Fresh

+0.72%

since Aug 24

LQAI · Weight increase · 2d

weight 1.630% → 1.700% (+0.070 pp)·stock up 0.6% in the 30 days before

Aug 19·entry $19.13·now $19.57Drifting

+2.30%

since Aug 19

LQAI · Weight decrease · 4d

stock down 1.0% in the 30 days before

Aug 17·entry $18.79·now $19.57

+4.15%

since Aug 17

LQAI · Weight decrease · 3d

stock up 0.9% in the 30 days before

Aug 14·entry $19.20·now $19.57

+1.93%

since Aug 14

LQAI · Weight decrease · 2d

stock up 2.7% in the 30 days before

Aug 13·entry $19.20·now $19.57

+1.93%

since Aug 13

LQAI · Weight decrease · 2d

stock down 2.3% in the 30 days before

Aug 10·entry $19.03·now $19.57

+2.84%

since Aug 10

LQAI · Weight decrease · 3d

stock down 4.1% in the 30 days before

Aug 3·entry $19.01·now $19.57

+2.95%

since Aug 3

LQAI · Weight decrease · 2d

stock down 0.5% in the 30 days before

Jul 31·entry $19.24·now $19.57

+1.72%

since Jul 31

LQAI · Weight increase · 3d

stock up 3.8% in the 30 days before

Jul 29·entry $19.79·now $19.57Fresh

-1.11%

since Jul 29

LQAI · Weight increase · 2d

stock up 3.2% in the 30 days before

Jul 28·entry $19.75·now $19.57Fresh

-0.91%

since Jul 28

LQAI · Weight increase · 3d

stock up 3.0% in the 30 days before

Jul 17·entry $18.98·now $19.57Drifting

+3.11%

since Jul 17

LQAI · Weight increase · 2d

stock up 4.2% in the 30 days before

Jul 16·entry $19.02·now $19.57Drifting

+2.89%

since Jul 16

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of May 31

AIEQ recently made a new entry into Kenvue, indicating a positive signal from that AI, while LQAI showed a recent trend of decreasing its weight after a slight increase. This mixed AI sentiment contrasts with the framework's overall 'Fail' verdict, which is primarily driven by the inability to confirm critical financial health metrics and valuation.

Circle of CompetenceKenvue's position in consumer staples with established brands suggests predictable unit economics suitable for long-term cash flow projections.
Economic MoatThe company benefits from strong brand power and established market positions for its consumer health products, creating durable competitive advantages.
ManagementSpecific information regarding management's candor, capital allocation discipline, or ownership stake is not provided.
Financial HealthInsufficient financial data, including 10-year ROE trend, operating margins, debt profile, and owner earnings, prevents a comprehensive assessment of financial health.
Margin of SafetyWithout an intrinsic value estimate, it is not possible to determine if the current price offers a margin of safety.

Kenvue, a consumer staples company with strong brands, passes the circle of competence and economic moat stages. However, a comprehensive assessment of its financial health, management quality, and intrinsic value is hindered by insufficient public data for several key criteria, leading to an overall 'Fail' verdict within this framework.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.